February 16, 2017
Calmare Therapy NJ USA clinical director Dr. Michael Cooney contributed “The 411 on Calmare Scrambler Therapy” to Pain News Network. The bylined article describes his clinical experience administering this newer therapy to help patients lessen or eliminate several types of diagnosed neuropathy, particularly CRPS / RSD, PHN, diabetic nerve pain, post-surgical pain and chemo-induced peripheral neuropathy (CIPN).
Dr. Cooney also discusses the merits of alternative medicine as a solution for treatment-resistant patients battling severe chronic pain.
Pain News Network, reaching more than 100,000 unique readers each month, is a non-profit, independent news source for information and commentary about chronic pain and pain management. The publication’s mission is to raise awareness about chronic pain and connect and educate pain sufferers, caregivers, healthcare providers and the public about the pain experience.
“I’ve followed this publication for some time and believed their readers would be open to learning more about Calmare Therapy, particularly the fact that it is drug-free, painless and has no side effects,” says Dr. Cooney.
“Personally and professionally, my biggest frustration is when our therapies do not achieve a successful patient outcome.
Often, “treatment-resistant” patients are forced to seek out more invasive procedures – surgeries, spinal cord stimulators, or powerful narcotics such as ketamine − where success has been uneven, but side effects can be significant.
I wasn’t comfortable recommending these “next level” neuropathic pain treatments for my patients. So my partner Dr. Robert Kelly and I spent two years looking for a non-invasive therapy that didn’t cause pain or come with added side effects.”